TheraRadar
← Back
Data updated: Mar 29, 2026

CADILA PHARMS LTD

CardiovascularMetabolicOncology
Generics

CADILA PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Metabolic, Oncology.

2013
Since
29
Drugs
-
Trials
487
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
4 drugs
Metabolic 25%
2 drugs
Oncology 13%
1 drugs
Dermatology 13%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Bayer big-pharma
Oncology, Cardiovascular, Dermatology, Metabolic
Merck big-pharma
Oncology, Cardiovascular, Metabolic
Baxter specialty
Cardiovascular, Oncology, Dermatology
Johnson & Johnson big-pharma
Oncology, Cardiovascular, Metabolic
Eli Lilly big-pharma
Metabolic, Oncology, Dermatology